Condyloma diagnosis, coding, and clinical documentation information for healthcare professionals. Learn about anogenital warts, venereal warts, HPV warts, and their associated ICD-10 codes. Find resources for accurate condyloma identification, treatment, and patient care. This comprehensive guide covers all aspects of condyloma from a medical perspective, including symptoms, causes, and prevention.
Also known as
Anogenital (venereal) warts
Genital warts caused by HPV infection.
Viral warts
Warts caused by various viral infections, including HPV.
Infections with a predominantly sexual mode of transmission
Includes various sexually transmitted infections like syphilis, chlamydia, and HPV.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Condyloma caused by HPV?
When to use each related code
| Description |
|---|
| Genital warts caused by HPV. |
| Cervical cell changes caused by HPV. |
| Anal cell changes caused by HPV. |
Lack of specific HPV type documented may lead to inaccurate coding and affect quality reporting.
Imprecise documentation of the anatomical location (e.g., cervix, anus) can cause coding errors and claim denials.
Insufficient documentation to distinguish condyloma from similar lesions can lead to incorrect diagnosis and coding.
Q: What are the most effective differential diagnosis strategies for Condyloma (Anogenital Warts) vs. other similar-appearing lesions?
A: Differentiating Condyloma (Anogenital Warts) from other lesions like molluscum contagiosum, seborrheic keratosis, or even squamous cell carcinoma requires a multifaceted approach. Visual inspection focusing on morphology (e.g., verrucous or papillomatous appearance for Condyloma) is crucial. Acetowhitening after application of 3-5% acetic acid can highlight subclinical lesions, particularly helpful for Condyloma. However, biopsy and histopathological examination remain the gold standard for definitive diagnosis, especially when features are atypical or there is suspicion of malignancy. High-resolution anoscopy or colposcopy may be indicated for enhanced visualization and targeted biopsies. Consider implementing a standardized algorithm incorporating these diagnostic modalities for optimal patient management. Explore how HPV DNA testing can be used in conjunction with other methods to improve diagnostic accuracy in challenging cases.
Q: How do current treatment guidelines recommend managing Condyloma (Venereal Warts/HPV Warts) in pregnant patients, considering both maternal and fetal safety?
A: Managing Condyloma in pregnant patients requires careful consideration of treatment modalities due to potential fetal risks. Topical treatments like trichloroacetic acid (TCA) or podophyllin are often preferred during pregnancy, but podophyllin resin is generally contraindicated. Surgical removal methods such as cryotherapy, electrocautery, or laser ablation can be used if topical treatments are ineffective but require careful application to minimize tissue damage. Imiquimod is typically avoided during pregnancy due to limited safety data. It's crucial to counsel pregnant patients about the potential for spontaneous regression of Condyloma postpartum. Learn more about the specific treatment guidelines recommended by professional organizations like the American College of Obstetricians and Gynecologists (ACOG) for evidence-based management strategies.
Patient presents with complaints consistent with anogenital warts, also known as condyloma or venereal warts. Physical examination reveals characteristic flesh-colored to grayish-white papules or plaques in the anogenital region. Lesions are described as exophytic, cauliflower-like, or flat. Patient reports (insert symptom if present, e.g., pruritus, discomfort, bleeding) associated with the lesions. Differential diagnosis includes molluscum contagiosum, seborrheic keratosis, and squamous cell carcinoma. HPV testing (specify type if performed) may be indicated. Diagnosis of condyloma is made based on clinical presentation. Treatment plan includes (specify treatment, e.g., topical imiquimod, cryotherapy, surgical excision) and patient education regarding HPV transmission, safe sex practices, and the potential for recurrence. Follow-up is scheduled for (specify timeframe) to monitor treatment response and assess for any complications such as scarring or infection. ICD-10 code A63.0 (Anogenital (venereal) warts) is assigned. Procedure codes (if applicable, e.g., for cryotherapy or excision) will be documented separately. Patient counseling regarding vaccination against HPV (Gardasil 9) was provided.